Sanuwave Health (OTC:SNWV) said yesterday it is partnering with HyperMed to sponsor a clinical investigation exploring Sanuwave’s DermaPace system designed for treating diabetic foot ulcers. The joint study will look to quantify the level of increased perfusion and oxygenation during and after treatment with the DermaPace, Suwanee, Ga.-based Sanuwave said. The study will use HyperMed’s Hyperview […]
CollPlant wins Israeli grant for BioInk 3D printed organs
Regenerative medicine company CollPlant said today it received agrant from the Israel Innovation Authority to help support its plant-based rhCollagen technology for tissue repairs. The grant will specifically support uses of its rhCollagen-based formulations intended for use as BioInk for 3D printing tissues and organs, the company said. The total budget for the program $1.2 million (NIS […]
Avita Medical touts publication of pivotal ReCell trial data
Avita Medical (ASX:AVH) today released results from a pivotal clinical trial of its ReCell autologous cell harvesting device in treating deep partial-thickness second-degree burns. The ReCell autologous cell harvesting device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, Avita said. Results from […]
InVivo Therapeutics prices $13m offering
InVivo Therapeutics (NSDQ:NVIV) today priced a public stock offering worth more than $13 million for the neurospinal scaffold it’s developing to treat spinal cord injuries. Cambridge, Mass.-based InVivo said it plans to float some 388,000 shares and another 388,000 warrants at a combined price of $2 per unit, plus 6.2 million pre-funded warrants and 6.2 million […]
PolarityTE aims to ‘wage war on skin grafts’ with regenerative tech
PolarityTE wants to eliminate skin grafts with its platform of regenerative technology. The Utah-based biotech is still new to the industry, but co-founders Denver Lough and Ned Swanson are betting that their company can take on the clinical standard of care for wound management. “No other product, whether it be a drug, a biologic device, or […]
Osiris levels $7m trade theft, breach-of-contract suit against MiMedx over Stability Biologics deal
Osiris Therapeutics leveled trade theft and breach-of-contract charges worth nearly $7 million against a regenerative medicine rival, stemming from the Stability Biologics acquisition by MiMedx (NSDQ:MDXG). Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after MiMedx paid $10 million for […]
DARPA is developing a human memory prosthesis: Here’s how
The Defense Advanced Research Projects Agency (DARPA) has successfully created what it is calling a human memory prosthesis, a system with electrodes implanted in the brain that restores memory function using a person’s own neural codes. DARPA has been working on restoring normal memory function in military personnel since 2013 in a program known as […]
8 women medtech innovators you need to know
As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine. X-rays on the battlefield, the American Red Cross, leprosy treatment and more — these advances happened because of women. As […]
MiMedx wins FDA regenerative med status for AmnioFix
MiMedx (NSDQ:MDXG) won regenerative medicine advanced therapy status from the FDA for its injectable osteoarthritis drug, AmnioFix, the company announced this week. The U.S. regulatory watchdog told MiMedx that the company provided sufficient preliminary evidence that AmnioFix could address unmet needs for patients with osteoarthritis of the knee. Get the full story at our sister site, […]
Medtronic wins one lawsuit, settles state AG probes over Infuse
Medtronic (NYSE:MDT) said a shareholder lawsuit brought over its Infuse bone-growth protein is over, after the U.S. Supreme Court declined to review the case. Approved in 2002 for use in spinal fusion surgery, Infuse at one point had annual sales of nearly $1 billion. The bone-grafting product has since been linked to abnormal bone growth, […]
Collagen Solutions jumps on positive study data
Shares in Collagen Solutions (LON:COS) rose this week after the U.K.-based company touted positive data from an eight-year study of 15 patients who received ChondroMimetic implants to repair cartilage defects in their knees. The company plans to apply for CE Mark clearance in the European Union for its ChrondroMimetic implant based on the results from […]
- 1
- 2
- 3
- …
- 34
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+